相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of an Individualized Immune-Related Prognostic Risk Score in Lung Squamous Cell Cancer
Yuan Zhuang et al.
FRONTIERS IN ONCOLOGY (2021)
Across-Site Differences in the Mechanism of Alcohol-Induced Digestive Tract Carcinogenesis: An Evaluation by Mediation Analysis
Yuriko N. Koyanagi et al.
CANCER RESEARCH (2020)
Acquired Resistance to Immune Checkpoint Inhibitors
Adam J. Schoenfeld et al.
CANCER CELL (2020)
Acquired Resistance to Immune Checkpoint Blockade Therapies
Xianda Zhao et al.
CANCERS (2020)
Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans
Felix A. Dingler et al.
MOLECULAR CELL (2020)
The failure of two major formaldehyde catabolism enzymes (ADH5 and ALDH2) leads to partial synthetic lethality in C57BL/6 mice
Jun Nakamura et al.
GENES AND ENVIRONMENT (2020)
Combination of host immune metabolic is biomarkers for the PD-1 blockade cancer immunotherapy
Ryusuke Hatae et al.
JCI INSIGHT (2020)
Alcohol inhibits T-cell glucose metabolism and hepatitis in ALDH2-deficient mice and humans: roles of acetaldehyde and glucocorticoids
Yanhang Gao et al.
GUT (2019)
Effect of sex on the efficacy of patients receiving immune checkpoint inhibitors in advanced non-small cell lung cancer
Chengdi Wang et al.
CANCER MEDICINE (2019)
Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLC
Yoshihiro Ohue et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Perspective on immune oncology with liquid biopsy, peripheral blood mononuclear cells, and microbiome with non-invasive biomarkers in cancer patients
A. Mitsuhashi et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Discovery of 4 exonic and 1 intergenic novel susceptibility loci for leprosy
Z. Wang et al.
CLINICAL GENETICS (2018)
Genetic variants of ALDH2-rs671 and CYP2E1-rs2031920 contributed to risk of hepatocellular carcinoma susceptibility in a Chinese population
Xinping Ye et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Predictive Biomarkers for Checkpoint Immunotherapy: Current Status and Challenges for Clinical Application
Nancy Tray et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Aldehyde Dehydrogenase 2 Polymorphism Is a Predictor of Smoking Cessation
Hiroyuki Masaoka et al.
NICOTINE & TOBACCO RESEARCH (2017)
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH)
Solange Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Mizuki Nishino et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Neutrophils dominate the immune cell composition in non-small cell lung cancer
Julia Kargl et al.
NATURE COMMUNICATIONS (2017)
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
Chien-Hua Tseng et al.
ONCOTARGET (2017)
Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung
Aoi Kuroda et al.
RESPIRATORY RESEARCH (2017)
Combination of ALDH2 and ADH1B polymorphisms is associated with smoking initiation: A large-scale cross-sectional study in a Japanese population
Hiroyuki Masaoka et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Aldehyde dehydrogenase 2 deficiency blunts compensatory cardiac hypertrophy through modulating Akt phosphorylation early after transverse aorta constriction in mice
Guang Xia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
Justin F. Gainor et al.
CLINICAL CANCER RESEARCH (2016)
Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis
Justin Chien et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Roles of defective ALDH2 polymorphism on liver protection and cancer development
Akiko Matsumoto et al.
ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2016)
The PD1:PD-L1/2 Pathway from Discovery to Clinical implementation
Kankana Bardhan et al.
FRONTIERS IN IMMUNOLOGY (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer
Antonio Calles et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Characterization of Aldh2-/- mice as an age-related model of cognitive impairment and Alzheimer's disease
Yohan D'Souza et al.
MOLECULAR BRAIN (2015)
Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
Patrick Royston et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis
Hiroko Hoshi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function
Juan I. Garaycoechea et al.
NATURE (2012)
Metabolic Remodeling Induced by Mitochondrial Aldehyde Stress Stimulates Tolerance to Oxidative Stress in the Heart
Jin Endo et al.
CIRCULATION RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Critical roles of the PI3K/Akt signaling pathway in T cell development
Marisa A. Juntilla et al.
IMMUNOLOGY LETTERS (2008)
Akt1 and Akt2 are required for αβ thyrnocyte survival and differentiation
Marisa M. Juntilla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cutting edge:: T cell development requires the combined activities of the p110γ and p110δ catalytic isoforms of phosphatidylinositol 3-kinase
LMC Webb et al.
JOURNAL OF IMMUNOLOGY (2005)
分享论文
